{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:14:31Z","timestamp":1780481671095,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 111-2314-B-A49-092-MY3"],"award-info":[{"award-number":["NSTC 111-2314-B-A49-092-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-A49-082-MY3"],"award-info":[{"award-number":["NSTC 112-2314-B-A49-082-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG6M0312"],"award-info":[{"award-number":["CMRPG6M0312"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CORPG6N0181"],"award-info":[{"award-number":["CORPG6N0181"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG6M0311"],"award-info":[{"award-number":["CMRPG6M0311"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jfma.2025.09.039","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T22:58:19Z","timestamp":1759791499000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and clinical impact of JAK2-CHIP: Association with Parkinsonism and hematologic changes in a population cohort"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5921-5346","authenticated-orcid":false,"given":"Cih-En","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hsien","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Ren","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yung","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8594-3360","authenticated-orcid":false,"given":"Meng-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsing-Yi","family":"Tsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chian-Pei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hsuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6794-7229","authenticated-orcid":false,"given":"Chih-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jfma.2025.09.039_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.jfma.2025.09.039_bib2","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.jfma.2025.09.039_bib3","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"6465","key":"10.1016\/j.jfma.2025.09.039_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jfma.2025.09.039_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"6327","key":"10.1016\/j.jfma.2025.09.039_bib6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jfma.2025.09.039_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.exphem.2017.08.001","article-title":"Tet2 restrains inflammatory gene expression in macrophages","volume":"55","author":"Cull","year":"2017","journal-title":"Exp Hematol"},{"issue":"6","key":"10.1016\/j.jfma.2025.09.039_bib8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","article-title":"Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms","volume":"129","author":"Vainchenker","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jfma.2025.09.039_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.jfma.2025.09.039_bib10","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/ajh.26008","article-title":"Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management","volume":"95","author":"Tefferi","year":"2020","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.jfma.2025.09.039_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1182\/blood.2019001113","article-title":"Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population","volume":"134","author":"Cordua","year":"2019","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.jfma.2025.09.039_bib12","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood-2013-03-460154","article-title":"Myeloproliferative neoplasms and thrombosis","volume":"122","author":"Barbui","year":"2013","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jfma.2025.09.039_bib13","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/leu.2008.253","article-title":"Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation","volume":"22","author":"Landolfi","year":"2008","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.jfma.2025.09.039_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.119.044362","article-title":"Genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis","volume":"141","author":"Bick","year":"2020","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.jfma.2025.09.039_bib15","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/CIRCULATIONAHA.109.900191","article-title":"Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management","volume":"121","author":"Lanza","year":"2010","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jfma.2025.09.039_bib16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/01.STR.26.7.1171","article-title":"White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home","volume":"26","author":"Ylikoski","year":"1995","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.jfma.2025.09.039_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2017.96","article-title":"A clinicopathological approach to the diagnosis of dementia","volume":"13","author":"Elahi","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"19","key":"10.1016\/j.jfma.2025.09.039_bib18","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.2106\/JBJS.O.00071","article-title":"Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update","volume":"97","author":"Mont","year":"2015","journal-title":"J Bone Joint Surg Am"},{"issue":"10","key":"10.1016\/j.jfma.2025.09.039_bib19","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.3324\/haematol.2018.187989","article-title":"Quantitative competitive allele-specific TaqMan duplex PCR (qCAST-Duplex PCR) assay: a refined method for highly sensitive and specific detection of JAK2V617F mutant allele burdens","volume":"103","author":"Hsu","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.jfma.2025.09.039_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood-2006-03-009472","article-title":"JAK2(V617F): prevalence in a large Chinese hospital population","volume":"109","author":"Xu","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jfma.2025.09.039_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3324\/haematol.2010.033191","article-title":"The JAK2 V617F somatic mutation, mortality and cancer risk in the general population","volume":"96","author":"Nielsen","year":"2011","journal-title":"Haematologica"},{"issue":"7913","key":"10.1016\/j.jfma.2025.09.039_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41586-022-04785-z","article-title":"The longitudinal dynamics and natural history of clonal haematopoiesis","volume":"606","author":"Fabre","year":"2022","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.jfma.2025.09.039_bib23","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/ng.2413","article-title":"Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis","volume":"44","author":"Busque","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jfma.2025.09.039_bib24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/asheducation.V2012.1.571.3798557","article-title":"Thrombotic disease in the myeloproliferative neoplasms","volume":"2012","author":"Falanga","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jfma.2025.09.039_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12974-014-0227-y","article-title":"Pentraxin 3 mediates neurogenesis and angiogenesis after cerebral ischaemia","volume":"12","author":"Rodriguez-Grande","year":"2015","journal-title":"J Neuroinflammation"},{"issue":"429","key":"10.1016\/j.jfma.2025.09.039_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7729","article-title":"Oncogenic JAK2(V617F) causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms","volume":"10","author":"Prestipino","year":"2018","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.jfma.2025.09.039_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","article-title":"The role of toll-like receptors and neuroinflammation in parkinson's disease","volume":"19","author":"Heidari","year":"2022","journal-title":"J Neuroinflammation"},{"issue":"11","key":"10.1016\/j.jfma.2025.09.039_bib28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"18","key":"10.1016\/j.jfma.2025.09.039_bib29","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1523\/JNEUROSCI.4658-15.2016","article-title":"Inhibition of the JAK\/STAT pathway protects against alpha-synuclein-induced neuroinflammation and dopaminergic neurodegeneration","volume":"36","author":"Qin","year":"2016","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.jfma.2025.09.039_bib30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41531-024-00784-1","article-title":"Parkinson's disease is associated with clonal hematopoiesis with TET2 mutation","volume":"10","author":"Woo","year":"2024","journal-title":"npj Parkinson's Dis"},{"issue":"7569","key":"10.1016\/j.jfma.2025.09.039_bib31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature15252","article-title":"Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jfma.2025.09.039_bib32","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0033-1343890","article-title":"JAK2 mutation-related disease and thrombosis","volume":"39","author":"Vannucchi","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"4 Pt 2","key":"10.1016\/j.jfma.2025.09.039_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-2006-942759","article-title":"The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia","volume":"32","author":"Bellucci","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jfma.2025.09.039_bib34","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.3389\/fimmu.2020.02103","article-title":"Is there a role for basophils in cancer?","volume":"11","author":"Marone","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jfma.2025.09.039_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12484","article-title":"Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults","volume":"7","author":"Young","year":"2016","journal-title":"Nat Commun"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625005236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625005236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:05:06Z","timestamp":1773151506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664625005236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":35,"alternative-id":["S0929664625005236"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2025.09.039","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and clinical impact of JAK2-CHIP: Association with Parkinsonism and hematologic changes in a population cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2025.09.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}